Riskpilot← Back to searchSign inGet full accessHEMALI AS
ASActiveOrg 825348182Fjordalléen 18, 0250 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20201 employeeshemali.no
Revenue 2024
NOK 17K
-87% vs 2023
EBITDA margin
-1375.8%
+82% vs 2023
Equity ratio
84.7%
Financial strength
Net profit 2024
NOK -230K
-124% vs 2023
| Revenue | NOK 17K | -87% |
| EBITDA | NOK -232K | +82% |
| Net profit | NOK -230K | -124% |
| Total assets | NOK 9,6M | +0% |
| Equity | NOK 8,1M | -3% |
| Employees | 1 | — |
Legal name
HEMALI AS
Org number
825348182
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
22. juli 2020
Share capital
NOK 60 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Primært å være et alternativt og upolitisk talerør innen helse, mat og livstil, samt selge produkter relatert til det samme. Vi ønsker også å drive informasjonsarbeid innen helse, mat og livsstil. Artikler skal være basert på vitenskapelig forskning. Hemali as kan også investere i og samarbeide med andre selskap som har samme formål.
Address
Fjordalléen 18, 0250 Oslo
Website
hemali.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 100 | 12 | 231 | 131 | 17 |
| Staff expenses | −0 | −0 | −109 | −52 | 11 |
| EBITDA | −51 | −150 | −441 | −1 321 | −232 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −51 | −150 | −441 | −1 321 | −232 |
| Net financials | 0 | 0 | −2 | 2 267 | 2 |
| Profit before tax | −51 | −150 | −443 | 946 | −230 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −51 | −150 | −443 | 946 | −230 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 665 | 8 759 | 9 641 | 9 572 | 9 568 |
| Equity | −21 | 7 829 | 8 584 | 8 338 | 8 109 |
| Long-term debt | 8 410 | 765 | 931 | 1 219 | 1 442 |
| Short-term debt | 276 | 165 | 126 | 15 | 18 |
| Total debt | 8 686 | 930 | 1 057 | 1 234 | 1 460 |
EBITDA margin
-1375.8%
This company
15.8%
Market median
-8808% vs market
20202024
Equity ratio
84.7%
This company
38.2%
Market median
+122% vs market
20202024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-1364.1%
This company
8.1%
Market median
-16941% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-05-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nutra Invest As | Company | 45.1% | 45.1% | 2023 |
Hemali As | Company | 42.0% | 42.0% | 2023 |
| Individual | 3.8% | 3.8% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nutra Invest As
HEMALI AS Board members of HEMALI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Andreas Rønning | Chief Executive Officer | 0 companies |
| Cato Oddsett | Chairman | 0 companies |
| Lars Martin Inge Lindgren | Chairman | 0 companies |
| Anders Struksnæs | Board of Directors | 0 companies |
| Helge Onsum | Chairman | 0 companies |